-
CLAIMS DATA FOR POST-MARKET SAFETY INVESTIGATIONS: LESSONS FROM A REAL-WORLD ONCOLOGY COHORT
Mar 18, 2026, 21:38 PM -
PREDICTING TREATMENT-RESISTANT DEPRESSION AMONG MEDICARE BENEFICIARIES USING MACHINE LEARNING
Mar 18, 2026, 21:38 PM -
A STATISTICAL MODELING FRAMEWORK FOR PROCESS-MINED REAL-WORLD DATA SUPPORTING HTA OF MULTIPLE MYELOMA TECHNOLOGIES IN A BRAZILIAN HEALTH MAINTENANCE ORGANIZATION
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF INTENSIVE VERSUS STANDARD HYPERTENSIVE THERAPY AMONG TYPE 2 DIABETIC PATIENTS WITH HYPERTENSION
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE UTILIZATION AND ECONOMIC BURDEN OF HERPES ZOSTER IN IMMUNOCOMPETENT OLDER ADULTS IN THE UNITED STATES: A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
GENERIC ENTRY AND THE EARLY IMPACT ON U.S. PHARMACEUTICAL SPENDING
Mar 18, 2026, 21:38 PM -
COMPARATIVE RISK OF PSYCHIATRIC OUTCOMES WITH GLP-1RAS ACROSS METABOLIC INDICATIONS: A POPULATION-BASED RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
INTEGRATION OF PATIENT-REPORTED OUTCOME MEASURES IN LOWER URINARY TRACT SYMPTOMS ATTRIBUTED TO BENIGN PROSTATIC HYPERPLASIA (LUTS/BPH) CARE: QUALITATIVE INSIGHTS FOR IMPLEMENTATION STRATEGIES
Mar 18, 2026, 21:38 PM -
EARLY PATTERNS IN SECOND ORPHAN DRUG DESIGNATIONS FOLLOWING EXPANSION OF THE ORPHAN DRUG EXCLUSION
Mar 18, 2026, 21:38 PM -
MULTI-INDICATION BUDGET IMPACT ANALYSIS OF SUBCUTANEOUS IGPRO20 PRE-FILLED SYRINGES FOR THE TREATMENT OF PID, SID, AND CIDP IN ITALY
Mar 18, 2026, 21:38 PM -
TARGETED LITERATURE REVIEW TO IDENTIFY US CLAIMS-BASED ALGORITHMS FOR ALZHEIMER’S DISEASE
Mar 18, 2026, 21:38 PM -
THE PATTERNS OF COUPON OFFSETS IN GLUCAGON-LIKE PEPTIDE AGONIST USE:EVIDENCE FROM NATIONAL, ALL-PAYER PHARMACY CLAIMS
Mar 18, 2026, 21:38 PM -
A SEQUENTIAL MATCHING APPROACH TO ADDRESS IMMORTAL TIME BIAS: APPLICATION TO THE MGUS STUDY
Mar 18, 2026, 21:38 PM -
PREDICTORS OF PATIENT-DIRECTED DISCHARGE AMONG EMERGENCY DEPARTMENT PATIENTS WITH OPIOID USE DISORDER
Mar 18, 2026, 21:38 PM -
A COST CALCULATOR FOR ESTIMATING DIRECT MEDICAL COST AVOIDANCE FROM SECOND-LINE SELADELPAR USE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
Mar 18, 2026, 21:38 PM -
COMPARING ESTABLISHED AND NOVEL INDEX DATE SELECTION METHODS: A SIMULATION STUDY IN TWO CLINICAL CONTEXTS
Mar 18, 2026, 21:38 PM -
COST COMPARISON OF RFVIIA AND PLASMA-DERIVED FACTOR VII FOR BLEEDING MANAGEMENT IN COLOMBIA
Mar 18, 2026, 21:38 PM -
QUANTIFYING THE IMPACT OF ADHERENCE TO HEREDITARY CANCER TESTING ON COLORECTAL CANCER BURDEN: A MICROSIMULATION MODEL
Mar 18, 2026, 21:38 PM -
STUDENT-REPORTED BARRIERS TO ISPOR CONFERENCE ATTENDANCE: A NORTH AMERICA VS. REST OF WORLD ANALYSIS
Mar 18, 2026, 21:38 PM -
SAME EVIDENCE, DIFFERENT DECISIONS: HOW REGULATORY STANDARDS SHAPE ORPHAN DRUG APPROVALS
Mar 18, 2026, 21:38 PM
